Evidence map›Paper›PMID 40665254›Full record

ArticleBMC infectious diseases2025

Patterns of immune recovery in people living with HIV who initiated antiretroviral therapy as late presenters.

Sandra Pinto-Cardoso, Monserrat Chávez-Torres, Mariana López-Filloy, Santiago Ávila-Ríos, Karla Romero-Mora, Amy Peralta-Prado

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sandra Pinto-CardosoDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan 4502, Colonia Sección XVI, Tlalpan, Ciudad de México, 14080, México. sandra.pintocardoso.cieni@gmail.com.
Monserrat Chávez-TorresDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan 4502, Colonia Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Mariana López-FilloyDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan 4502, Colonia Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Santiago Ávila-RíosDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan 4502, Colonia Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Karla Romero-MoraDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan 4502, Colonia Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Amy Peralta-PradoDepartamento del Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan 4502, Colonia Sección XVI, Tlalpan, Ciudad de México, 14080, México. draamyperaltaprado@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSome people living with HIV-1 (PWH) do not reconstitute their CD4 + T cell counts despite complete inhibition of HIV-1 replication on antiretroviral therapy (AR); these are known as immunological nonresponders (INR). This is a retrospective analysis to estimate the prevalence of INR in a hospital-based cohort of PWH who initiated ART with severe immunodeficiency and/or opportunistic infections. We also explored mechanisms of poor immune recovery, with emphasis on the gut microbiome.

methodsAll PWH included in this study achieved virologic suppression (plasma viral load < 200 copies of HIV-1/mL) six months after ART initiation and remained virally suppressed thereafter. INR and immunological responders (IR) were defined according to the CD4 + T cell counts after 24-months on ART initiation (< 350 or ≥ 350 cells/µL, respectively). Both INR (n = 15) and IR (n = 15) were matched for nadir CD4 (< 200 cells/µL). Uninfected individuals at high-risk of HIV infection were also included (n = 40). We assessed indirect markers linked to HIV disease progression (markers of innate immune activation and enterocyte damage) and gut dysbiosis using cryopreserved plasma and stool samples using Enzyme-Linked immunosorbent Assay and 16S ribosomal DNA sequencing.

resultsThe estimated prevalence of INR after 24-months on ART was 50%. Microbial translocation, gut epithelial damage and gut dysbiosis persisted in PWH on ART, yet were not different between INR and IR. After adjusting for multiple comparisons, we found that INR had lower alpha diversity (Shannon) and higher levels of sCD163 compared with PWoH (p = 0.013 and p = 0.017, respectively). No differentially-abundant genera were identified; differences in the gut microbiome were primarily driven by a Prevotella and Bacteroides gradient, which is linked to sexual practices (men who have sex with men, MSM). Indeed, in our cohort, most INR were non-MSM, while PWoH were all MSM.

conclusionsIn the Instituto Nacional de Enfermedades Respiratorias, a tertiary reference centre, a disproportionate number of individuals are diagnosed with HIV-1 with severe immunodeficiency and/or opportunistic infections; they represent a high-risk population for the INR phenotype. Our data on possible mechanisms of the INR phenotype linked to the gut microbiome yielded modest results, precluding any decisive conclusions. Interventions to boost the immune function in this at-risk population are warranted and deserving of further studies.

Indexed as

Anti-HIV AgentsHIV InfectionsImmune ReconstitutionAdultCD4 Lymphocyte CountFemaleGastrointestinal MicrobiomeHIV-1HumansMaleMiddle AgedRetrospective StudiesViral LoadAnti-HIV AgentsGut dysbiosisImmune recoveryImmunological nonrespondersMicrobial translocationNadir CD4

Identifiers

PMID40665254
PMCPMC12261816

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.